Search clinical trials for: severe pneumonia

Total 17675 results

Federal University of Rio Grande do Sul
Hospital de Clinicas de Porto Alegre; Conselho Nacional de Desenvolvimento... and other collaborators

Completed

Lung Function, Exercise Capacity and Health-Related Quality of Life After Severe COVID-19

COVID-19 | SARS-CoV-2 Infection

Brazil
Institut Curie

Completed

COVID-19 Study of the Serological Response Against the Severe Acute Respiratory Syndrome (SARS) Coronavirus 2 (CoV-2) Virus in 2 Types of Employees, Hospital and Non-hospital, at Institute Curie and Institute Pasteur (Curie-O-SA)

Volunteers From the Institute Curie and Institute Pasteur Staff Who Are Not Showing Active SARS-CoV-2 Infection

France
University Hospital of Patras

Completed

Tocilizumab Versus Baricitinib in Patients With Severe COVID-19

COVID-19

Greece
Central Hospital, Nancy, France

Completed

Characterization in 18F-FDG PET-CT of Brain and Lung Lesions in Subjects With a History of Severe COVID-19 (TEP-COV)

Covid-19

France
BioAegis Therapeutics Inc.

Completed

Rhu-pGSN for Severe Covid-19 Pneumonia

Sars-CoV2

Romania, Spain
Gilead Sciences

Terminated

Study of Obeldesivir in Participants With COVID-19 Who Have a High Risk of Developing Serious or Severe Illness (BIRCH)

COVID-19

Spain, Japan, Korea, Republic of, Taiwan, Bulgaria, Mexico, South Africa, United Kingdom, Portugal, Romania, Hungary, Brazil, Canada, France, Italy, Poland, Singapore, Turkey
Heidelberg University

Terminated

RescuE pLAsma eXchange in Severe COVID-19 (RELAX)

Covid19 | Therapeutic Plasma Exchange

Germany
Rutgers, The State University of New Jersey
University Hospital - Newark, NJ

No longer available

Investigational COVID-19 Convalescent Plasma Infusion for Severely or Life-threateningly Ill COVID-19 Patients

COVID-19 | SARS-CoV 2 | SARS-CoV Infection

United States
Royal Free Hospital NHS Foundation Trust
Roche Diagnostics

Completed

SARS-CoV-2 (COVID-19) Antibody PrevalencE in an Adult London HIV Cohort (SCAPE-HIV)

Covid19 | SARS-CoV Infection | HIV-1-infection

United Kingdom
Savana Research
Castilla-La Mancha Health Service

Active, not recruiting

Clinical Characteristics and Prognostic Factors of Patients With COVID-19 (Coronavirus Disease 2019)

COVID-19 Infection

Spain
Canadian Cancer Trials Group
Canadian Cancer Society (CCS); ATGen Canada Inc; Ontario Institute for Cancer... and other collaborators

Active, not recruiting

Immunization With IMM-101 vs Observation for Prevention of Respiratory and Severe COVID-19 Related Infections in Cancer Patients at Increased Risk of Exposure (COV-IMMUNO)

Covid-19 | Cancer

Canada
Rohto Pharmaceutical Co., Ltd.

Completed

A Study of ADR-001 in Patients With Severe Pneumonia Caused by SARS-CoV-2 Infection (COVID-19)

SARS-CoV-2 Infection( COVID-19 )

Japan
Quadram Institute Bioscience
Norfolk and Norwich University Hospitals NHS Foundation Trust; James Paget...

Active, not recruiting

COVID-19 Persistence in Stool (CoPS)

SARS-CoV Infection

United Kingdom
National MS Center Melsbroek

Completed

Protection Against Severe Coronavirus Disease 2019 in Patients With Multiple Sclerosis Stratified According to Disease Modifying Treatment (PASCOMS)

Multiple Sclerosis

Belgium
University of California, San Francisco
Rowpar Pharmaceuticals, Inc.

Terminated

Antiseptic Mouthwash / Pre-Procedural Rinse on SARS-CoV-2 Load (COVID-19) (AMPoL)

Coronavirus Infections | COVID-19 | SARS-CoV 2 | Pharyngeal Diseases | Severe Acute Respiratory Syndrome Coronavirus 2 | Virus Disease

United States
The Republican Research and Practical Center for...
Belarusian State Medical University

Enrolling by invitation

Study of Leukocyte Immunophenotype and the Lipid Transport System as Predictive Biomarkers of Severe Bacterial Infections

Sepsis | Pneumonia, Bacterial | Infective Endocarditis

Belarus
Pharmacyclics LLC.
Janssen Research & Development, LLC

Active, not recruiting

Phase 1/2 Dose Finding and Safety Study of Ibrutinib in Pediatric Subjects With Chronic Graft Versus Host Disease (cGVHD)

Chronic Graft Versus Host Disease

United States, Spain, Korea, Republic of, Australia, Austria, Canada, France, Germany, Israel, Italy, Netherlands, Russian Federation, United Kingdom
University Hospital of Ferrara

Active, not recruiting

Pro-thrombotic Status in Patients With SARS-Cov-2 Infection (ATTAC-Co)

Severe Acute Respiratory Syndrome Coronavirus 2

Italy
Instituto de Investigación Marqués de Valdecilla
Gerencia Atencion Primaria Area 3; Gerencia de atención primaria área 1; Gerencia... and other collaborators

Completed

PREEMPTIVE THERAPY WITH COLCHICINE IN PATIENTS OLDER THAN 60 YEARS WITH HIGH RISK OF SEVERE PNEUMONIAE DUE TO CORONAVIRUS (COLCHI-COVID)

SARS-CoV-2 Infection (COVID-19)

Spain
Hospital Moinhos de Vento

Active, not recruiting

Cohort Study for the Assessment of Long-term Impact of COVID-19 Among Moderate and Severe COVID-19 Patients in Brazil

COVID-19 | Quality of Life | Disability Physical | Disabilities Mental

Brazil
University of Arizona
Senhwa Biosciences, Inc.

Terminated

Silmitasertib (CX-4945) in Patients With Severe Coronavirus Disease 2019 (COVID-19) (CX4945)

Coronavirus

United States
National Institute of Allergy and Infectious Diseases...

Completed

Surveillance of Individuals Following SARS-CoV-2 Infection

COVID-19

United States
Swiss Tropical & Public Health Institute
University of Nairobi; PATH; Cheikh Anta Diop University, Senegal; Burnet Institute

Completed

Tools for the Integrated Management of Childhood Illness: Cross-country Quasi-experimental Pre-post Study in Kenya and Senegal (TIMCI)

Pneumonia | Hypoxia | Childhood Severe Illness | Primary Health Care | Referreal and Consultation | Decision Support Systems, Clinical | Oxymetry

Kenya, Senegal
University of Michigan

Completed

Michigan Medicine COVID-19 Cohort: Clinical Characteristics, Inflammatory Markers and Outcomes of Patients Hospitalized for COVID-19 (M2C2)

Kidney Diseases | Inflammation | Covid19 | SARS-CoV Infection

United States
Medesis Pharma SA

Terminated

NanoMn®_COVID-19 A Prospective, Multicenter, Randomized, Placebo-controlled, Parallel-group, Double-blind Trial to Evaluate the Clinical Efficacy of NanoManganese® on Top of Standard of Care, in Adult Patients With Moderate to Severe Coronavirus Disease 2019 (COVID-19)

COVID-19 Pandemic

Brazil
Massachusetts General Hospital

Completed

COVID-19 Testing Sample Acquisition Throughput and Efficiency (HexapodBooth)

Covid19 | SARS-CoV Infection | Respiratory Viral Infection | Personal Protective Equipment

United States
Assistance Publique - Hôpitaux de Paris

Completed

Combined Use of a Respiratory Broad Panel mPCR and Procalcitonin to Reduce Duration of Antibiotics Exposure in Patients With Severe Community-Acquired Pneumonia (MULTI-CAP)

Community-acquired Pneumonia

France
Octapharma

Completed

Observational, Retrospective Study to Evaluate Coagulation Changes and the Influence of Antithrombin III Treatment in Patients With Severe COVID-19 Infection

Covid19

Austria, France, Germany, Sweden
Sidney Kimmel Comprehensive Cancer Center at Johns...

Terminated

Camostat With Bicalutamide for COVID-19 (COMBO)

Coronavirus Infection | Covid19 | SARS-CoV Infection

United States
University Hospital, Bordeaux

Completed

Efficacy of Vaccination Against COVID-19 in Patients Presenting a Neuromuscular Disease With Severe Amyotrophy (CANNEMUSS)

COVID-19 | Neuromuscular Diseases | Amyotrophy

France
CureVac
German Federal Ministry of Education and Research

Completed

A Study to Evaluate the Safety and Immunogenicity of Vaccine CVnCoV in Healthy Adults in Germany for COVID-19

Severe Acute Respiratory Syndrome | Covid19 | SARS-CoV-2 | Coronavirus

Germany
Australian and New Zealand Intensive Care Research...
The Alfred

Completed

The REDEEM Pilot Study: A Feasibility RCT of Early ECMO in Severe Acute Respiratory Infection, Including COVID-19, WHO (REDEEM)

Covid19 | Mechanical Ventilation Complication | Severe Acute Respiratory Infection

Australia, Germany
Sound Pharmaceuticals, Incorporated

Enrolling by invitation

SPI-1005 Treatment in Severe COVID-19 Patients

Coronavirus Infection | Covid19 | Corona Virus Infection | Coronavirus

United States
Daewoong Pharmaceutical Co. LTD.

Terminated

Efficacy and Safety of DWJ1248 With Remdesivir in Severe COVID-19 Patients

Severe COVID-19

Korea, Republic of
CureVac
German Federal Ministry of Education and Research

Completed

A Dose-Confirmation Study to Evaluate the Safety, Reactogenicity and Immunogenicity of Vaccine CVnCoV in Healthy Adults for COVID-19

Severe Acute Respiratory Syndrome | Covid19 | SARS-CoV-2 | Coronavirus

Panama, Peru
Chengdu Zenitar Biomedical Technology Co., Ltd

Active, not recruiting

Study of Flonoltinib Maleate Tablets in the Treatment of Severe Novel Coronavirus (COVID-19) Infection

COVID-19

China
Fifth Affiliated Hospital, Sun Yat-Sen University

Active, not recruiting

Risk Factors for Severe Disease in Hospitalized Patients With COVID-19 and the Effect of Azvudine Treatment: a Retrospective Cohort Study

COVID-19

China
Lisa Barrett
Nova Scotia Health Authority; Dalhousie University

Active, not recruiting

Treatment of Moderate to Severe Coronavirus Disease (COVID-19) in Hospitalized Patients

COVID-19

Canada
Queen Mary University of London
GlaxoSmithKline

Completed

Efficacy of Mouthwashes in Reducing Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Viral Load in the Saliva (COVID-19)

Covid19 | Coronavirus

United Kingdom
Deutsches Rotes Kreuz DRK-Blutspendedienst Baden-Wurttemberg-Hessen

Completed

A Clinical Trial of Convalescent Plasma Compared to Best Supportive Care for Treatment of Patients With Severe COVID-19 (CAPSID)

COVID-19

Germany
University Hospital, Ghent
UCB Pharma

Completed

Zilucoplan® in Improving Oxygenation, Short-, Longterm Outcome of COVID19 Patients With Acute Hypoxic Respiratory Failure (ZILU-COV)

COVID-19

Belgium
Immune Biosolutions Inc

Completed

Phase 1&2 Study to Evaluate the Safety & Efficacy of Inhaled IBIO123 in Severe COVID-19 Illness

COVID-19

Ukraine, South Africa
GeneOne Life Science, Inc.

Active, not recruiting

GLS-1027 for the Prevention of Severe Pneumonitis Caused by SARS-CoV-2 Infection (COVID-19)

SARS-CoV Infection | Pneumonitis

Korea, Republic of, Puerto Rico, United States, Bulgaria, North Macedonia
Chang Gung Memorial Hospital

Completed

Application of Serial Body Composition Change for Risk Prediction in Treating Patients With Severe Pneumonia

Pneumonia

Taiwan
Apogenix GmbH

Terminated

Asunercept for the Treatment of Patients With Moderate to Severe COVID-19 Disease (ASUCOV)

COVID-19

Spain, Germany, France, Italy, South Africa, India, Austria, Georgia, Poland
Rigel Pharmaceuticals

Completed

Double-Blind, Randomized, Placebo-Controlled, Multi-Center Phase 3 Study to Evaluate the Efficacy and Safety of Fostamatinib in COVID-19 Subjects

Pneumonia, Viral | Pneumonia | Covid19 | SARS (Severe Acute Respiratory Syndrome) | SARS-Associated Coronavirus as Cause of Disease Classified Elsewhere | SARS Pneumonia

United States, Argentina, Brazil, Mexico
aTyr Pharma, Inc.

Completed

Study to Evaluate the Safety and Efficacy of ATYR1923 (Efzofitimod) In Participants With Severe Pneumonia Related to COVID-19

SARS-CoV-2 (COVID-19) Severe Pneumonia

United States, Puerto Rico
University Hospital, Montpellier

Completed

Longitudinal Follow-up of Patients With Chronic Inflammatory Rheumatisms (CIRs) Vaccinated Against COVID-19 Compared to Patients Refusing Vaccination (COVID-RIC3)

COVID-19 | Rheumatic Diseases | SARS-CoV Infection

France
Emory University
National Cancer Institute (NCI)

Active, not recruiting

Best Supportive Care With or Without Low Dose Whole Lung Radiation Therapy for the Treatment of COVID-19 (RESCUE1-19)

Severe Acute Respiratory Syndrome | Pneumonia | Symptomatic COVID-19 Infection Laboratory-Confirmed

United States
Airway Therapeutics, Inc.

Terminated

A Clinical Safety Study on AT-100 in Treating Adults With Severe COVID-19 Infection or Severed Community Acquired Pneumonia

COVID-19 | Undefined

United States

Search clinical trials for: severe pneumonia

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Hong Kong

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations